InMode Ltd.
INMD Healthcare Medical Devices
InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.
Follow INMD
InMode Ltd. (INMD) EV/Sales
As of 16 October 2026, InMode Ltd. (INMD) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.7× (March 2026) to 23.9× (November 2021); the current reading is higher than 3% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | (42.30%) |
| FY2024 | 1.8× | (18.60%) |
| FY2023 | 2.3× | (56.42%) |
| FY2022 | 5.2× | (65.15%) |
| FY2021 | 14.9× | 111.77% |
| FY2020 | 7.0× | 15.61% |
| FY2019 | 6.1× | 165.58% |
| FY2018 | 2.3× | 0.00% |
| FY2017 | 2.3× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 9.05% |
| Mar 2026 | 0.9× | (17.16%) |
| Dec 2025 | 1.1× | (5.59%) |
| Sep 2025 | 1.1× | 12.37% |
| 30 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AHCO AdaptHealth Corp. compare | 0.8× |
| INMD InMode Ltd. | 0.9× |
| LMRI Lumexa Imaging Holdings, Inc. compare | 1.0× |
| VREX VAREX IMAGING compare | 1.2× |
| QDEL QuidelOrtho Corporation compare | 1.4× |
| CTKB Cytek Biosciences, Inc. compare | 2.0× |
| PRCT PROCEPT BioRobotics Corporation compare | 2.5× |
| SIBN SiBone compare | 3.6× |
| BBNX Beta Bionics, Inc. compare | 4.6× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)